Dyadic International faces a precarious fundamental outlook characterized by erratic, milestone-dependent revenue that fails to cover a rigid SG&A cost structure exceeding $1.2M per quarter. The company's reliance on equity-based compensation and a deteriorati...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 12, 2026 | -$0.06-71.4% vs -$0.04 | $961,138-6.3% vs $1M |
Q2 2026 May 13, 2026 | -$0.05-25.0% vs -$0.04 | $1M+22.9% vs $903,750 |
Q2 2026 Mar 25, 2026 | -$0.06-100.0% vs -$0.03 | $564,345-58.0% vs $1M |
Q4 2025 Nov 12, 2025 | -$0.06-50.0% vs -$0.04 | $1M-13.3% vs $1M |
Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
Dyadic International Inc. (NASDAQ: DYAI - Get Free Report) passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.88 and traded as low as $0.3527. Dyadic International shares last traded at $0.4244, with a volume of 490,904 shares. Analysts Set New Price Targets Separately,
JUPITER, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI) (the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences, food and nutrition, bio-industrial and biopharmaceutical markets, today announced definitive agreements with an institutional investor for the purchase and sale of shares of Common Stock in a registered direct offering with a concurrent private placement of warrants to the same investor.
Dyadic International, Inc. (DYAI) Q2 2026 Earnings Call Transcript
Benchmark DYAI against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Dyadic International, Inc. (DYAI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.41 | $15.12M | -1.80 | -64.74% | -597.63% | -397.8% | — | |
| $1.38 | $148.43M | -2.76 | 18.61% | -39.55% | -74.36% | — | |
| $1.45 | $352.95M | -10.36 | 849.33% | -119.93% | -50.64% | — | |
| $158.47 | $9.87B | -121.90 | 20.32% | -31.66% | -29.89% | — | |
| $1.80 | $98.97M | -1.41 | 15.57% | -490.71% | -27.23% | — | |
| $24.37 | $2.51B | -30.09 | 120.01% | -54.75% | -7.7% | — |
Dyadic International, Inc. (DYAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Dyadic International, Inc. (DYAI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 14, 2026·SEC
Aug 12, 2026·SEC
Jul 24, 2026·SEC
Get notified when DYAI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Dyadic International, Inc. (DYAI) stock FAQ — growth, dividends, profitability & financials explained
Dyadic International, Inc. (DYAI) reported $3.5M in revenue for fiscal year 2025. This represents a 1544% increase from $0.2M in 2003.
Dyadic International, Inc. (DYAI) saw revenue decline by 64.7% over the past year.
Dyadic International, Inc. (DYAI) reported a net loss of $7.6M for fiscal year 2025.
Dyadic International, Inc. (DYAI) has a return on equity (ROE) of -397.8%. Negative ROE indicates the company is unprofitable.
Dyadic International, Inc. (DYAI) had negative free cash flow of $7.4M in fiscal year 2025, likely due to heavy capital investments.
